South Dakota recalls

Arrow International JACC catheter kits contain lidocaine, bupivacaine, and sodium chloride from a supplier with quality control problems. The injectable components may not work properly or could be sterile-compromised, risking serious infection if used.

Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple PICC and JACC catheter kits. The anesthetic and saline components may be ineffective or contaminated, which could cause serious infection or other life-threatening complications if used.

Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple catheter and arterial line kits. The supplier's products showed signs of ineffectiveness and potential sterility problems, which could cause serious harm if compromised injectable products are used.

Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality problems in multiple central venous catheter kits. The supplier's products had reports of ineffectiveness, and if sterility is compromised, these injectable drugs could cause serious infection or other life-threatening complications.

Arrow International included anesthetic and saline components from a supplier with quality issues in several percutaneous central venous catheter (CVC) kits. The supplier's products showed limited reports of drug ineffectiveness, and compromised sterility in injectable products could cause serious injury.

Arrow International included injectable medications (lidocaine, bupivacaine, and sodium chloride) from a supplier with quality issues in several catheter kit models. If the sterility of these water-based injectable products is compromised, patients could face serious or life-threatening infections.

Arrow International hemodialysis kits contain lidocaine, bupivacaine, and saline solution from a supplier with quality control problems. The contaminated materials may not work as intended, and compromised sterility in injectable products could cause serious harm to patients.

Arrow International included injectable medications (lidocaine, bupivacaine, and sodium chloride) from a supplier with quality problems into hemodialysis kits. The supplier's products may not be sterile or effective, which could cause serious injury if used.

Arrow International included anesthetic medications (lidocaine, bupivacaine) and saline from a supplier with quality issues in multiple epidural catheter kits. The supplier's products may not be sterile or effective, and compromised sterility in injectable products can cause serious infection or other life-threatening complications.

Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple PICC (peripherally inserted central catheter) kit models. The supplier's products may be ineffective or contaminated, and compromised sterility in injectable products can cause serious infection or injury.

Arrow International recalled multiple central venous catheter kits that contain lidocaine, bupivacaine, and saline solution from a supplier with quality issues. The supplier's products may have compromised sterility, which could reduce drug effectiveness and pose serious health risks if the injectable solution is contaminated.

Arrow International included lidocaine, bupivacaine, and saline solutions from a supplier with known quality problems in multiple arterial and radial artery catheter kits. The supplier's medications showed signs of ineffectiveness, and if the sterility of these injectable products was compromised, patients could face serious injury.

Arrow International recalled several PICC (peripherally inserted central catheter) kits and stylets because they contain injectable medications from a supplier with quality issues. The medications—lidocaine, bupivacaine, and saline—may be ineffective or contaminated, which could cause serious injury if used.

Arrow International included local anesthetic drugs (lidocaine and bupivacaine) from a supplier with quality issues into several pacing procedure kits. The supplier's drugs had limited reports of ineffectiveness, and compromised sterility in injectable products could cause serious infection or other life-threatening complications.

Arrow International included anesthetic medications (lidocaine and bupivacaine) and saline solution from a supplier with quality problems in its biopsy system kits. The supplier had reports of drug ineffectiveness, and compromised sterility in injectable products could cause serious injury.

Arrow International included lidocaine, bupivacaine, and saline solutions from a supplier with quality problems in multiple anesthesia and nerve block kits. The supplier's products may be ineffective or contaminated, which could cause serious infection or other life-threatening complications if the sterility of these injectable solutions is compromised.

Arrow International paracentesis kits (models AK-00376 and ASK-00376-VCU) contain anesthetic and saline solutions from a supplier with quality issues and reports of drug ineffectiveness. If the sterility of these injectable products is compromised, they could cause serious or life-threatening infections or complications during the procedure.

A software error in certain Automated Impella Controller devices (used to manage left heart support blood pumps) may affect device function. The error affects controllers with software versions 6.0.1, 6.0.2, 6.0.3, 7.1 and above across multiple regions worldwide.

A blender component in certain Datex-Ohmeda Panda Freestanding Warmers can loosen over time, causing the device to deliver oxygen at a concentration that does not match the setting the user selected. This can result in infants receiving too much or too little oxygen, potentially causing harm.

A component in certain Giraffe and Panda warming systems can loosen during maintenance, causing the device to deliver oxygen at a concentration different from what the clinician set. This can result in too much oxygen (hyperoxia) or too little oxygen (hypoxia) being delivered to the patient.

A component in certain Giraffe Stand-alone Infant Resuscitation Systems can loosen during maintenance, causing the device to deliver oxygen at the wrong concentration. Infants may receive too much or too little oxygen, risking serious harm.

Dkiru LLC's Adndale Magnesium Glycinate Gummies 400 mg contain melatonin that is not listed on the label. The affected product is sold in 90-count plastic bottles (UPC 860008784551) with three affected lot numbers expiring between August and September 2026. Melatonin is a sleep aid not declared in the ingredient list, which poses a risk to consumers who may not expect it or who should avoid it due to other medications or health conditions.

Nutrisystem Chocolate Cheesecake 2 oz frozen packages contain soy that is not declared on the label. People with a soy allergy who eat this product could have an allergic reaction. The recall affects 5,184 units with lot code CH030426 distributed across 25 states.

Mid Dolciaria .155 Crunchy Cannoli Gluten Free desserts contain chlorophyll colors (E140 and E141) that are not approved for use in the United States. The affected lot was distributed in the USA.

Mid Dolciaria Cannoli Siciliani dessert boxes contain unapproved food colorings (chlorophyll E140 and E141) that are not permitted in the U.S. The affected product was distributed in the USA with a best-before date of 10/17/2026.

The FDA identified manufacturing deficiencies during inspection of Med Pride Triple Antibiotic Ointment (1oz tubes). Multiple lots do not meet required manufacturing standards. No injuries have been reported.

Med Pride Triple Antibiotic Ointment packets were found to have manufacturing quality deficiencies during an FDA inspection. The affected lots do not meet federal quality standards, though no injuries have been reported.

The FDA found manufacturing deficiencies during an inspection of the facility that produces Med Pride Hydrocortisone Cream 1%. These deviations from proper manufacturing standards affected multiple lots of the product currently still within their expiration dates.

The FDA found manufacturing quality control problems (CGMP deviations) during an inspection of the facility that makes Med Pride Hydrocortisone Cream 1%. Multiple lots of the product are affected. No injuries have been reported.

The FDA found manufacturing deficiencies during an inspection of Med Pride 1% Clotrimazole Antifungal Cream. These deficiencies do not meet federal good manufacturing practice standards. About 5,755 tubes across multiple lots are affected.